Role of Extended Chemotherapy in Advanced Ovarian Cancer Patients with High Posttreatment Serum CA-125 Levels
- Authors
- Kang, S[Kang, Sokbom]; Kim, TJ[Kim, Tae-Joong]; Seo, SS[Seo, Sang-Soo]; Kim, BG[Kim, Byoung-Gie]; Bae, DS[Bae, Duk-Soo]; Park, SY[Park, Sang-Yoon]
- Issue Date
- 2011
- Keywords
- CA-125; Chemotherapy; Optimal cytoreduction; Ovarian cancer
- Citation
- GYNECOLOGIC AND OBSTETRIC INVESTIGATION, v.72, no.1, pp.50 - 54
- Indexed
- SCIE
SCOPUS
- Journal Title
- GYNECOLOGIC AND OBSTETRIC INVESTIGATION
- Volume
- 72
- Number
- 1
- Start Page
- 50
- End Page
- 54
- URI
- https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/72516
- DOI
- 10.1159/000322438
- ISSN
- 0378-7346
- Abstract
- Background: We aimed to determine whether the inclusion of additional cycles of carboplatin-paclitaxel is beneficial to patients with high posttreatment serum CA-125 levels. Methods: Among patients who achieved remission after six cycles of carboplatin-paclitaxel chemotherapy, those with CA-125 of 10-35 U/ml at the time of remission were divided into two groups (group A: six cycles of standard chemotherapy vs. group B: two or more additional cycles) and were analyzed. Results: Among the 436 patients with advanced epithelial ovarian cancer, 154 patients (46.8%) had CA-125 of 10-35 U/ml at the time of remission. Fifty-six patients (36.4%) received two or more cycles after the first six cycles of chemotherapy (group B). The addition of two or more cycles of chemotherapy did not improve the progression-free survival (p = 0.660). There was no statistical difference in the rates of CA-125 falling to ! 10 U/ml between the two groups (p = 0.256). Moreover, the degree of CA-125 decrease after six cycles of chemotherapy was similar regardless of the additional cycles (p = 0.656). Conclusion: The addition of two or more cycles of standard chemotherapy based on posttreatment CA-125 levels was not beneficial. Copyright (C) 2011 S. Karger AG, Basel
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/skku/handle/2021.sw.skku/72516)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.